Coya Therapeutics reveals pricing for IPO closing in early January
Several weeks after filing for an IPO, a Houston biotech firm has announced pricing for its shares with the offering running through early January.
Building "Bridges" Across the Bayou City!
Several weeks after filing for an IPO, a Houston biotech firm has announced pricing for its shares with the offering running through early January.